Phase I trial of valaciclovir, the L-valyl ester of acyclovir, in patients with advanced human immunodeficiency virus disease.

Valaciclovir, the L-valyl ester of acyclovir, is rapidly and extensively converted in humans to acyclovir after oral administration by first-pass metabolism. A phase I study was conducted in two cohorts of volunteers with advanced human immunodeficiency virus (HIV) disease (absolute CD4 lymphocyte c...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Jacobson, M A, Gallant, J, Wang, L H, Coakley, D, Weller, S, Gary, D, Squires, L, Smiley, M L, Blum, M R, Feinberg, J
Médium: Artigo
Jazyk:Inglês
Vydáno: 1994
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC284589/
https://ncbi.nlm.nih.gov/pubmed/7979285
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky